Neuland Laboratories — Q1 FY17 Earnings Presentation

4 slides from Neuland Laboratories's earnings presentation, 2016

Slide 2: Business Saliency
Business Saliency The graphs below show the Saliency of the Q1 of FY-16 & FY-17 and over the last three quarters YoY Analysis Quarter on Quarter Movement 4% 23% 22% 16% 23% 24% 30% 26% 29% 25% 25% 29% 66% 53% 57% 51% 47% 47% Q1FY16 Q1FY17 Q2FY16 Q3FY16 Q4FY16 Q1FY17 CMS NICHE PRIME CMS NICHE PRIME N
Slide 3: CMS Business Depth
CMS Business Depth This Indicator gives the number of molecules (APIs and Intermediates) contributing to the revenue in the Quarter. This number is classified in two parts as Clinical & Commercial based on the status of the respective molecules. The intent here is to give an idea of the depth of the
Slide 4: Thank You
A WHERE OPPORTUNITY BECOMES REALITY Thank You